| Views | |
|---|---|
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial | 147 |
| October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | |
|---|---|---|---|---|---|---|---|
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial | 1 | 3 | 1 | 5 | 7 | 16 | 2 |
| Views | |
|---|---|
| SCOPUS22138587-2021-9-4-SID85102485610-p1.pdf | 8 |
| Views | |
|---|---|
| Russia | 45 |
| Views | |
|---|---|
| Kazan | 45 |